Skip to main content
European Urology Open Science logoLink to European Urology Open Science
. 2022 Aug 27;44:52–53. doi: 10.1016/j.euros.2022.08.012

Corrigendum re “Hypofractionated Postoperative Radiotherapy for Prostate Cancer: Is the Field Ready Yet?” [Eur Urol Open Sci 2020;22:9–16]

Sean Mahase 1, Himanshu Nagar 1,
PMCID: PMC9449545  PMID: 36093321

In Section 3.5 and Table 2, citation of [17] is incorrect and the reference should be to a different paper. These should now read as follows.

3.5. Clinical evidence to date

As randomized trials are ongoing, there is currently no prospective phase III evidence comparing hypofractionated with conventionally fractionated postoperative prostate radiotherapy. Thus, current efficacy is largely based on retrospective analyses (Table 2). Lee et al. [41] retrospectively evaluated men who underwent salvage radiotherapy for biochemical relapse following prostatectomy.

Table 2.

Studies reporting efficacy of hypofractionated radiotherapy for postoperative prostate cancer

Study Patients (n) Total dose (Gy) Number of fractions Technique Median follow-up (mo) Biochemical recurrence–free survival (%) DM (%) OS (%) Acute gastrointestinal toxicity (≥G3), n Acute genitourinary toxicity (≥G3), n Late gastrointestinal Toxicity (≥G3), n Late genitourinary toxicity (≥G3), n
Lee et al. (2004) [41] 61 50–52.5 20 3D 36 74 0 100 0 0 0 1
Wong et al. (2008) [31] 50 65–70 26–28 IMRT 24 72.9 2 96 0 0 0 0
Kruser et al. (2011) [32] 108 65 26 IMRT 32.4 67 2.7 99 0 1 0 0
Lewis et al. (2016) [33] 56 57.5–65 23–26 IMRT 48 75 NR 96 0 0 2 4
Fersino et al. (2017) [34] 125 65.5–71.4 28–30 IMRT 18 85.5 NR NR 0 1 0 2
Macchia et al. (2017) [35] 124 62.5 25 IMRT 60 86.5 1 100 0 1 NR NR
Tandberg et al. (2018) [36] 167 65 26 IMRT 38.6 78.4 4 94.3 0 1 11 1
Picardi et al. (2018) [37]a 918 50–72.8 20–29 2D, 3D and IMRT 36 74–85 NR NR NR NR NR NR
Siepe et al. (2018) [38]a 1208 37.8–74.2 21–28 3D and IMRT 60 86.5 NR NR 0 NR NR NR
Chin et al. (2020) [39] 112 52.5 20 3D 120 51.5 16 75 NR NR NR NR

2D = two-dimensional volume imaging; 3D = three-dimensional conformal radiotherapy; G3 = grade 3; DM = distant metastases; IMRT = intensity-modulated radiation therapy; n = number of patients; NR = not reported; OS = overall survival.

a

Systematic review.



Conflicts of interest: The authors have nothing to disclose.

Reference

  • 41.Lee L.W., McBain C.A., Swindell R., Wylie J.P., Cowan R.A., Logue J.P. Hypofractionated radiotherapy as salvage for rising prostate-specific antigen after radical prostatectomy. Clin Oncol. 2004;16:517–522. doi: 10.1016/j.clon.2004.07.006. [DOI] [PubMed] [Google Scholar]

Articles from European Urology Open Science are provided here courtesy of Elsevier

RESOURCES